Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“Honored to join global colleagues and leaders to deliver the message tomorrow at the United Nations for The Last Mile Series at United Nations General Assembly UNGA79, hosted by the International Cancer Patient Coalition (ICPC).
When innovation doesn’t reach people, breakthroughs stall. This high-level dialogue—at the UN—will focus on aligning policy, AI, Precision Oncology, early detection to build a global action framework that connects innovation to impact.
Sept 24, 2025 | 15:00–18:00 EST
UN HQ, Conference Room 5
Let’s move from promise to people.”
More from Vivek Subbiah on OncoDaily.